Activation of the microglial Nlrp3 inflammasome has been proposed as a key contributor to the progression of AD pathology in the APP/PS1 and CRND8-APP models of Aβ-induced neuropathy (33, 52). This evidence concerns the gene APP and Alzheimer disease.